Literature DB >> 30071253

Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection.

Bruna Dos Santos Rodrigues1, Hiroshi Oue2, Amrita Banerjee1, Takahisa Kanekiyo2, Jagdish Singh3.   

Abstract

Gene therapy has become a promising approach for neurodegenerative disease treatment, however there is an urgent need to develop an efficient gene carrier to transport gene across the blood brain barrier (BBB). In this study, we strategically designed dual functionalized liposomes for efficient neuronal transfection by combining transferrin (Tf) receptor targeting and enhanced cell penetration utilizing penetratin (Pen). A triple cell co-culture model of BBB confirmed the ability of the liposomes to cross the barrier layer and transfect primary neuronal cells. In vivo quantification of PenTf-liposomes demonstrated expressive accumulation in the brain (12%), without any detectable cellular damage or morphological change. The efficacy of these nanoparticles containing plasmid β-galactosidase in modulating transfection was assessed by β-galactosidase expression in vivo. As a consequence of accumulation in the brain, PenTf-liposomes significantly induced gene expression in mice. Immunofluorescence studies of brain sections of mice after tail vein injection of liposomes encapsulating pDNA encoding GFP (pGFP) illustrate the superior ability of dual-functionalized liposomes to accumulate in the brain and transfect neurons. Taken together, the multifunctional liposomes provide an excellent gene delivery platform for neurodegenerative diseases.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood brain barrier; Dual-functional liposomes; Gene delivery; Penetratin; Transferrin

Mesh:

Substances:

Year:  2018        PMID: 30071253      PMCID: PMC6138570          DOI: 10.1016/j.jconrel.2018.07.043

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  88 in total

Review 1.  Assessment of the blood-brain barrier in CNS drug discovery.

Authors:  Phil Jeffrey; Scott Summerfield
Journal:  Neurobiol Dis       Date:  2009-08-05       Impact factor: 5.996

2.  Modulation of angiotensin II binding sites in neuronal cultures by mineralocorticoids.

Authors:  C Sumners; M J Fregly
Journal:  Am J Physiol       Date:  1989-01

Review 3.  Non-viral vectors for gene-based therapy.

Authors:  Hao Yin; Rosemary L Kanasty; Ahmed A Eltoukhy; Arturo J Vegas; J Robert Dorkin; Daniel G Anderson
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

4.  Heterogeneous distribution of transferrin receptors on parenchymal and nonparenchymal liver cells: biochemical and morphological evidence.

Authors:  W Vogel; A Bomford; S Young; R Williams
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

5.  Topology of Surface Ligands on Liposomes: Characterization Based on the Terms, Incorporation Ratio, Surface Anchor Density, and Reaction Yield.

Authors:  Shang-Hsuan Lee; Yusuke Sato; Mamoru Hyodo; Hideyoshi Harashima
Journal:  Biol Pharm Bull       Date:  2016       Impact factor: 2.233

6.  Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide.

Authors:  Maria Gregori; Mark Taylor; Elisa Salvati; Francesca Re; Simona Mancini; Claudia Balducci; Gianluigi Forloni; Vanessa Zambelli; Silvia Sesana; Maria Michael; Christos Michail; Claire Tinker-Mill; Oleg Kolosov; Michael Sherer; Stephen Harris; Nigel J Fullwood; Massimo Masserini; David Allsop
Journal:  Nanomedicine       Date:  2016-10-19       Impact factor: 5.307

7.  Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection.

Authors:  Gitanjali Sharma; Amit Modgil; Buddhadev Layek; Kanwardeep Arora; Chengwen Sun; Benedict Law; Jagdish Singh
Journal:  J Control Release       Date:  2013-01-23       Impact factor: 9.776

8.  Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.

Authors:  Zhen-Zhen Yang; Jing-Quan Li; Zhan-Zhang Wang; Da-Wen Dong; Xian-Rong Qi
Journal:  Biomaterials       Date:  2014-03-30       Impact factor: 12.479

Review 9.  Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.

Authors:  Christos Tapeinos; Matteo Battaglini; Gianni Ciofani
Journal:  J Control Release       Date:  2017-08-26       Impact factor: 9.776

10.  In vivo toxicity of cationic micelles and liposomes.

Authors:  Kristina Bram Knudsen; Helle Northeved; Pramod E K Kumar; Anders Permin; Torben Gjetting; Thomas L Andresen; Steen Larsen; Karen Malene Wegener; Jens Lykkesfeldt; Kim Jantzen; Steffen Loft; Peter Møller; Martin Roursgaard
Journal:  Nanomedicine       Date:  2014-08-25       Impact factor: 5.307

View more
  17 in total

1.  In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy.

Authors:  Sanjay Arora; Jagdish Singh
Journal:  Int J Pharm       Date:  2021-09-20       Impact factor: 5.875

Review 2.  Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases.

Authors:  Meihua Luo; Leo Kit Cheung Lee; Bo Peng; Chung Hang Jonathan Choi; Wing Yin Tong; Nicolas H Voelcker
Journal:  Adv Sci (Weinh)       Date:  2022-07-18       Impact factor: 17.521

Review 3.  Gene Therapy: The Next-Generation Therapeutics and Their Delivery Approaches for Neurological Disorders.

Authors:  Abhik Paul; Michael G Collins; Hye Young Lee
Journal:  Front Genome Ed       Date:  2022-06-22

4.  In vitro and in vivo characterization of CPP and transferrin modified liposomes encapsulating pDNA.

Authors:  Bruna Dos Santos Rodrigues; Takahisa Kanekiyo; Jagdish Singh
Journal:  Nanomedicine       Date:  2020-05-30       Impact factor: 5.307

Review 5.  Cell and Gene Therapies for Mucopolysaccharidoses: Base Editing and Therapeutic Delivery to the CNS.

Authors:  Chloe L Christensen; Rhea E Ashmead; Francis Y M Choy
Journal:  Diseases       Date:  2019-06-26

6.  Recombinant expressing angiopep-2 fused anti-VEGF single chain Fab (scFab) could cross blood-brain barrier and target glioma.

Authors:  Xuemei Ji; Hongyan Wang; Yue Chen; Junfei Zhou; Yu Liu
Journal:  AMB Express       Date:  2019-10-15       Impact factor: 3.298

7.  Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.

Authors:  Bruna Dos Santos Rodrigues; Sushant Lakkadwala; Takahisa Kanekiyo; Jagdish Singh
Journal:  Int J Nanomedicine       Date:  2019-08-14

Review 8.  Biomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows.

Authors:  Daniel González-Nieto; Rocío Fernández-Serra; José Pérez-Rigueiro; Fivos Panetsos; Ricardo Martinez-Murillo; Gustavo V Guinea
Journal:  Cells       Date:  2020-04-26       Impact factor: 6.600

Review 9.  Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles.

Authors:  Yamir Islam; Andrew G Leach; Jayden Smith; Stefano Pluchino; Christopher R Coxon; Muttuswamy Sivakumaran; James Downing; Amos A Fatokun; Meritxell Teixidò; Touraj Ehtezazi
Journal:  Adv Sci (Weinh)       Date:  2021-03-15       Impact factor: 16.806

Review 10.  Modeling blood-brain barrier pathology in cerebrovascular disease in vitro: current and future paradigms.

Authors:  Anuska V Andjelkovic; Svetlana M Stamatovic; Chelsea M Phillips; Gabriela Martinez-Revollar; Richard F Keep
Journal:  Fluids Barriers CNS       Date:  2020-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.